Oct 5, 2016
EMERGO SUMMARY OF KEY POINTS:
The Saudi Arabian government has officially shifted oversight of certain borderline products from medical device to pharmaceutical regulation.
A recent circular from the Saudi Food and Drug Authority (SFDA) (link in Arabic) explains that the products identified below may no longer be registered as medical devices in the country:
Instead, the SFDA now regulates these borderline products as drugs. However, existing medical device registrations for these products will remain valid until they expire, at which point registration holders will have to submit new applications for approval according to SFDA pharmaceutical requirements.
According to Emergo consultants in Riyadh, some manufacturers had previously registered these products as medical devices, while others had registered them as drugs. Thus, the SFDA revised its stance on borderline products to address ongoing issues regarding conflicting regulatory requirements and pricing.
For more details on Saudi Arabia’s medical device approval process, download our whitepaper or watch our video overview.
The Saudi Food & Drug Authority (SFDA), the Kingdom of Saudi Arabia’s medical device market regulator, has published new guidance on requirements for conducting clinical investigations in the country.
The Saudi Food & Drug Authority (SFDA) has issued new guidance on labeling requirements for medical devices approved for sale in the Kingdom of Saudi Arabia (KSA).